Literature DB >> 9243286

The role of dendritic cells in T cell activation.

K Ni1, H C O'Neill.   

Abstract

Dendritic cells (DC) are distinguishable from other antigen-presenting cells by their potent antigen-presenting capacity. They are not only efficient at presenting peptide antigen but can also process and present soluble protein antigen sto antigen-specific T cells and cloned T cell lines. They are very strong stimulators of both allogeneic and syngeneic mixed lymphocyte reactions and have a unique capacity to stimulate naive T cells. The potent functional capacity of DC is related to a high-level expression of major histocompatibility complex class I/II molecules and constitutive expression of costimulatory molecules, such as CD80/CD86, as well as heat stable antigen, CD40 and the leucocyte function antigen (LFA) family of adhesion molecules. Recent studies have shown that DC are also involved in regulation of the immune response via induction of both central and peripheral tolerance.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9243286     DOI: 10.1038/icb.1997.35

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  42 in total

1.  Magnetic nanoparticles for imaging dendritic cells.

Authors:  Saho Kobukai; Richard Baheza; Jared G Cobb; Jack Virostko; Jingping Xie; Amelie Gillman; Dmitry Koktysh; Denny Kerns; Mark Does; John C Gore; Wellington Pham
Journal:  Magn Reson Med       Date:  2010-05       Impact factor: 4.668

2.  Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases.

Authors:  Max A Cheng; Emily Farmer; Claire Huang; John Lin; Chien-Fu Hung; T-C Wu
Journal:  Hum Gene Ther       Date:  2018-03-16       Impact factor: 5.695

3.  Combined therapy of transcatheter hepatic arterial embolization with intratumoral dendritic cell infusion for hepatocellular carcinoma: clinical safety.

Authors:  Y Nakamoto; E Mizukoshi; H Tsuji; Y Sakai; M Kitahara; K Arai; T Yamashita; K Yokoyama; N Mukaida; K Matsushima; O Matsui; S Kaneko
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

4.  CD4+ T cell-independent DNA vaccination against opportunistic infections.

Authors:  Mingquan Zheng; Alistair J Ramsay; Myles B Robichaux; Corrine Kliment; Christopher Crowe; Rekha R Rapaka; Chad Steele; Florencia McAllister; Judd E Shellito; Luis Marrero; Paul Schwarzenberger; Qiu Zhong; Jay K Kolls
Journal:  J Clin Invest       Date:  2005-11-23       Impact factor: 14.808

Review 5.  Role of the unfolded protein response in determining the fate of tumor cells and the promise of multi-targeted therapies.

Authors:  Kunyu Shen; David W Johnson; David A Vesey; Michael A McGuckin; Glenda C Gobe
Journal:  Cell Stress Chaperones       Date:  2017-09-27       Impact factor: 3.667

6.  Equine Arteritis Virus Has Specific Tropism for Stromal Cells and CD8+ T and CD21+ B Lymphocytes but Not for Glandular Epithelium at the Primary Site of Persistent Infection in the Stallion Reproductive Tract.

Authors:  Mariano Carossino; Alan T Loynachan; Igor F Canisso; R Frank Cook; Juliana R Campos; Bora Nam; Yun Young Go; Edward L Squires; Mats H T Troedsson; Thomas Swerczek; Fabio Del Piero; Ernest Bailey; Peter J Timoney; Udeni B R Balasuriya
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

7.  Thiol peroxiredoxin, a novel allergen from Bombyx mori, modulates functions of macrophages and dendritic cells.

Authors:  Hui Wang; Wei Hu; Zhiling Liang; Lu Zeng; Jianjie Li; Hao Yan; Pingchang Yang; Zhigang Liu; Lianglu Wang
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

8.  CD4+ T cell-independent vaccination against Pneumocystis carinii in mice.

Authors:  M Zheng; J E Shellito; L Marrero; Q Zhong; S Julian; P Ye; V Wallace; P Schwarzenberger; J K Kolls
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

9.  Antibodies against listerial protein 60 act as an opsonin for phagocytosis of Listeria monocytogenes by human dendritic cells.

Authors:  A Kolb-Mäurer; S Pilgrim; E Kämpgen; A D McLellan; E B Bröcker; W Goebel; I Gentschev
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

Review 10.  Allo-reactive T cells for the treatment of hematological malignancies.

Authors:  J H F Falkenburg; I Jedema
Journal:  Mol Oncol       Date:  2015-10-24       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.